Intra-arterial Chemotherapy for Retinoblastoma: Where Do We Stand?
By: David H. Abramson, MD, FACS
With more than six years of data, the pros and cons of intra-arterial chemo are clearer than ever before.
Performance of Retinal Procedures in Previously Vitrectomized Eyes
By: ANKIT DESAI, MD; LEVENT AKDUMAN, MD
Unique challenges can arise in these patients.
Treatment of Pigment Epithelial Detachments in Age-related Macular Degeneration
By: BOZHO TODORICH, MD, PhD; KATHRYN PEPPLE, MD, PhD; Prithvi Mruthyunjaya, MD
A significant cause of visual morbidity in neovascular AMD, PEDs remain a treatment challenge.
Endoscopy-assisted Vitrectomy for Severe Endophthalmitis
By: CLAUDE R. BOSCHER, MD
In cases with initial VA limited to light perception,
better visualization can make a large difference.
Nutrition and Retina Health
By: STEVE LENIER, CONTRIBUTING EDITOR
AREDS taught us some things about this relationship,
but there’s much left to learn.
Upfront: From the Editor-in-Chief
By: Peter K. Kaiser, M.D.
The big picture
By: Jerry Helzner, Senior Editor
Can anti-VEGF trigger GA?; Ocriplasmin
approved for symptomatic VMA; A pill to treat
wet AMD?; FDA panel endorses Argus II for
RP; Study shows improvement in driver-related
outcomes; and more
Coding Q & A
Intravitreal injections: Keeping in compliance
By: Steve Charles, MD, FACS, FICS
Management of proliferative vitreoretinopathy
By: JAMES KNAUB, CONTRIBUTING EDITOR
Shining the light on retinal video